Close

BioMarin Pharma (BMRN) Will Seek Review of PTAB Exon 51 Composition of Matter Patent Decision (SRPT)

Go back to BioMarin Pharma (BMRN) Will Seek Review of PTAB Exon 51 Composition of Matter Patent Decision (SRPT)

Form 4 BIOMARIN PHARMACEUTICAL For: Sep 15 Filed by: BIENAIME JEAN JACQUES

September 19, 2016 6:42 PM EDT

.FormData { color: blue; background-color: white; font-size: 12px; font-family: Times, serif; } .FormDataR { color: blue; background-color: white; font-size: 12px; font-family: Times, serif; text-align: right; } .SmallFormData { color: blue; background-color: white; font-size: 10px; font-family: Times, serif; } .FootnoteData { color: green; background-color: white; font-size: 10px; font-family: Times, serif; } .FormNumText { font-size: 12px; font-weight: bold; font-family: arial, helvetica, sans-serif; } .FormAttention { font-size: 12px; font-weight: bold; font-family: helvetica; } .FormText { font-size: 12px; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left; } .FormTextR { font-size: 12px; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right; } .FormTextC { font-size: 12px; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center; } .FormEMText { font-size: 12px; font-style: italic; font-weight: normal;... More